Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1499 of 5804
-
New pill aims to ease schizophrenia psychosis
Symptom relief CompletedThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 6-week trial to evaluate the efficacy, safety, and tolerability of 2 fixed doses of CVL-231 (Emraclidine) (15 mg QD and 30 mg QD) in male and female adult participants who have schizophr…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New drug aims to tame muscle inflammation in myositis
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo shrinks rectal tumors before surgery
Disease control CompletedTASOX can be safely and efficaciously delivered after short course radiation, resulting in significant pathologic downstaging, allowing for an R0 pelvic resection, and providing local control in appropriately selected stage II/III rectal cancer patients treated with contemporary …
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can intensive arm training help stroke survivors regain movement?
Symptom relief CompletedThe evidence supporting routine provision of high-dose, high-intensity upper limb neurorehabilitation treatment for stroke survivors beyond the first few months after stroke is limited. The Queen Square Upper Limb (QSUL) programme provides 90 hours of upper limb neurorehabilitati…
Phase: PHASE2 • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Experimental gene therapy aims to restore sight in rare eye disease
Disease control OngoingThe purpose of the study is to evaluate the safety, tolerability and efficacy of LX101 in subjects with biallelic RPE65 mutation-associated inherited retinal dystrophy.
Phase: PHASE1 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Peer power: new study boosts HIV prevention in minority men
Prevention CompletedThe objective of this study is to develop an effective peer-driven intervention (PDI) approach and assess its feasibility and efficacy on pre-exposure prophylaxis (PrEP) uptake among men who have sex with men.
Phase: NA • Sponsor: The Miriam Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Teens with sickle cell disease get a brain boost to prep for adult care
Symptom relief Recruiting nowRandomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents with sickle cell disease for transition of care.
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can a common arthritis drug silence Blast-Induced tinnitus?
Symptom relief Recruiting nowThe purpose of this multi-site research study is to determine if Etanercept, compared to a placebo, significantly reduces the severity of tinnitus (ringing in the ears) associated with history of blast and/or noise exposure or associated with Traumatic Brain Injury (TBI) and/or c…
Phase: PHASE2 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could a vaccine train Kids' bodies to fight brain cancer?
Disease control OngoingPatients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells that express a protein called s…
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Mediterranean diet education may offer a simple way to lower blood pressure
Disease control CompletedAn experimental randomized controlled trial was conducted to evaluate the effects of Mediterranean diet education on blood pressure levels and quality of life in hypertensive patients. The sample size was determined using power analysis (n=70). Data were collected using a General…
Phase: NA • Sponsor: Uludag University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New triple therapy shows promise for resistant cancers
Disease control CompletedThis is a multicenter, open-label, dose-escalation and efficacy/safety Phase I/II study to assess RP2D, safety, tolerability and anti-tumor activity of Sintilimab + afuresertib + nab-paclitaxel or docetaxel administered as a combination therapy. This study is designed to identif…
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for rare clotting disorder: drug aims to prevent dangerous clots during surgery and delivery
Disease control Recruiting nowThe goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under when they receive Atenativ for surgical procedures or parturition.
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study: could a wearable heart monitor after fainting save lives?
Disease control Recruiting nowSyncope (fainting) is a common reason for emergency department (ED) presentation. Fainting can be caused by heart conditions such as irregular heart rhythm (arrhythmia) that can be life-threatening, structural heart problems, or serious conditions not related to the heart. The st…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy targets Hard-to-Treat lymphoma
Disease control OngoingThis study is an open-label Phase II trial of non-Hodgkin lymphoma patients receiving initial treatment with the immunomodulatory agent, pembrolizumab, plus low-dose (4 Gy x 5) involved-site radiotherapy. Eligible patients will have r/r disease with at least 2 sites of measurable…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Pill vs. IV: could a new drug beat the standard for deadly lung fungus?
Disease control CompletedPulmonary mucormycosis is a serious illness with high morbidity and mortality (approximately 57%). Surgery and antifungal therapy are central in the management of mucormycosis. Unlike rhino-orbital mucormycosis, surgery is not feasible in several patients with pulmonary mucormyco…
Phase: PHASE2 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Laser light to the brain may lift depression
Symptom relief CompletedNote: This registration is retained as a historical study record. Updated study information and subsequent protocol modifications are available under ClinicalTrials.gov Identifier NCT06934135, which serves as the actively maintained study registration. The Near-Infrared Transcra…
Phase: NA • Sponsor: Peruvian Clinical Research • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Sound waves vs. high blood pressure: new device shows promise
Disease control OngoingTo compare the antihypertensive effect of renal denervation with the Paradise™ system with that of a sham procedure in hypertensive patients receiving two antihypertensive drugs at the time of consent, and treated with a duo combination antihypertensive pill.
Phase: NA • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New imaging study reveals how drug tames Crohn's inflammation
Disease control CompletedCrohn's disease(CD),a type of inflammatory bowel disease(IBD), is a chronic intestinal recurrent inflammatory disease involving the entire digestive tract. And Ustekinumab, a monoclonal antibody against the p40 subunit of interleukin-12 and interleukin-23, is a newly targeted dru…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Shorter radiation shows promise for prostate cancer control
Disease control CompletedThe aim of the study is 1. Statistical evaluation of patients' characteristics who have intermediate \& high risk localized prostate cancer. 2. Statistical analysis of treatment efficacy of combined hormonal therapy \& hypo fractionated intensity modulated radiotherapy compared …
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo pill aims to curb weight gain in teens on antipsychotics
Disease control Recruiting nowTo compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC